Skip to content

Nanox Imaging Stock Rallies on FDA Submission for Multi-Source Nanox.ARC

Medical imaging technology firm Nanox Imaging (NASDAQ: NNOX) are rallying after the company announced it has submitted a 510(k) premarket notification application to the US Food and Drug Administration (FDA) for the first version of its multi-source Nanox.ARC 3-D digital tomosynthesis system.

Nanox.ARC is a 3-D tomosynthesis imaging system that produces scans of a human body part. The company said the first version of the multi-source Nanox.ARC will be followed by future Nanox.ARC versions.

“The 510(k) submission for the first version of our multi-source Nanox.ARC is an important achievement,” stated Ran Poliakine, Chairman and CEO of Nanox.

“There exists a significant unmet medical need globally for a more accessible and cost-effective medical imaging solution. If cleared by the FDA, we believe our Nanox.ARC 3-D digital tomosynthesis can address this need.”

Nanox Imaging shares are currently up 16.2% at $32.52.

Should You Invest in Nanox Imaging Shares?

One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now

Sam Boughedda
Sam Boughedda
Team Member

Sam is a trader and lead stock market writer at AskTraders. After starting his career in the forex market, Sam now focuses on stocks, specifically consumer staples. 

Stay ahead of the markets

Sign up to our free Morning Markets email, every weekday before the open.